PortfoliosLab logoPortfoliosLab logo
JDOC vs. FTXH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

JDOC vs. FTXH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jpmorgan Healthcare Leaders ETF (JDOC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

JDOC vs. FTXH - Yearly Performance Comparison


2026 (YTD)202520242023
JDOC
Jpmorgan Healthcare Leaders ETF
-3.96%15.36%-1.04%10.71%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
4.48%24.15%2.98%9.42%

Returns By Period

In the year-to-date period, JDOC achieves a -3.96% return, which is significantly lower than FTXH's 4.48% return.


JDOC

1D
2.32%
1M
-6.11%
YTD
-3.96%
6M
6.94%
1Y
5.14%
3Y*
5Y*
10Y*

FTXH

1D
2.61%
1M
-3.36%
YTD
4.48%
6M
21.14%
1Y
26.79%
3Y*
11.30%
5Y*
7.36%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


JDOC vs. FTXH - Expense Ratio Comparison

JDOC has a 0.65% expense ratio, which is higher than FTXH's 0.60% expense ratio.


Return for Risk

JDOC vs. FTXH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JDOC
JDOC Risk / Return Rank: 2121
Overall Rank
JDOC Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
JDOC Sortino Ratio Rank: 2020
Sortino Ratio Rank
JDOC Omega Ratio Rank: 1919
Omega Ratio Rank
JDOC Calmar Ratio Rank: 2424
Calmar Ratio Rank
JDOC Martin Ratio Rank: 2020
Martin Ratio Rank

FTXH
FTXH Risk / Return Rank: 6868
Overall Rank
FTXH Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 7171
Sortino Ratio Rank
FTXH Omega Ratio Rank: 6565
Omega Ratio Rank
FTXH Calmar Ratio Rank: 7575
Calmar Ratio Rank
FTXH Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JDOC vs. FTXH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jpmorgan Healthcare Leaders ETF (JDOC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JDOCFTXHDifference

Sharpe ratio

Return per unit of total volatility

0.30

1.28

-0.97

Sortino ratio

Return per unit of downside risk

0.54

1.78

-1.25

Omega ratio

Gain probability vs. loss probability

1.07

1.24

-0.17

Calmar ratio

Return relative to maximum drawdown

0.54

1.95

-1.41

Martin ratio

Return relative to average drawdown

1.24

5.94

-4.70

JDOC vs. FTXH - Sharpe Ratio Comparison

The current JDOC Sharpe Ratio is 0.30, which is lower than the FTXH Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of JDOC and FTXH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


JDOCFTXHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.30

1.28

-0.97

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

0.38

+0.21

Correlation

The correlation between JDOC and FTXH is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

JDOC vs. FTXH - Dividend Comparison

JDOC's dividend yield for the trailing twelve months is around 0.92%, less than FTXH's 1.23% yield.


TTM2025202420232022202120202019201820172016
JDOC
Jpmorgan Healthcare Leaders ETF
0.92%0.89%5.57%0.15%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.23%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%

Drawdowns

JDOC vs. FTXH - Drawdown Comparison

The maximum JDOC drawdown since its inception was -20.87%, smaller than the maximum FTXH drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for JDOC and FTXH.


Loading graphics...

Drawdown Indicators


JDOCFTXHDifference

Max Drawdown

Largest peak-to-trough decline

-20.87%

-32.11%

+11.24%

Max Drawdown (1Y)

Largest decline over 1 year

-9.68%

-12.74%

+3.06%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

Current Drawdown

Current decline from peak

-6.96%

-3.36%

-3.60%

Average Drawdown

Average peak-to-trough decline

-7.01%

-5.88%

-1.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.61%

4.68%

-0.07%

Volatility

JDOC vs. FTXH - Volatility Comparison

The current volatility for Jpmorgan Healthcare Leaders ETF (JDOC) is 5.67%, while First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a volatility of 6.24%. This indicates that JDOC experiences smaller price fluctuations and is considered to be less risky than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


JDOCFTXHDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.67%

6.24%

-0.57%

Volatility (6M)

Calculated over the trailing 6-month period

10.15%

12.06%

-1.91%

Volatility (1Y)

Calculated over the trailing 1-year period

17.04%

21.10%

-4.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.33%

16.15%

-1.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

14.33%

18.45%

-4.12%